市場調查報告書
商品編碼
1371964
到 2030 年生物催化現象和生物催化劑市場的預測:按類型、配方、應用和地區進行的全球分析Biocatalysis & Biocatalysts Market Forecasts to 2030 - Global Analysis By Type (Hydrolases, Transferases, Oxidoreductases, Lyases, Isomerases and Other Types), Formulation (Liquid, Gel and Powder), Application and By Geography. |
根據Stratistics MRC預測,2023年全球生物催化劑現象和生物催化劑市場規模將達到133.1億美元,並在預測期內以8.5%的年複合成長率成長,到2030年達到235.6億美元。
生物催化劑是指具有催化各種製程能力的生物(非人類)來源的化合物。生物催化劑是具有生物分解性、催化效率高、在良性環境中發揮作用等優點的有機材料。這些催化劑用於多種工業和商業性應用。生物催化劑廣泛應用於生物製藥、農業、纖維、生物燃料和其他生命科學領域。
根據美國農業部(USDA)統計,2018年,加拿大食品和飲料部門總銷售額為870億美元。
天然生物酵素擴大取代加工食品中的化學添加劑。此外,許多研究表明,加工食品中添加的生物防腐劑比危險化學物質更有利於消化健康。使用酵素等有機催化作用的生物催化在食品加工中具有許多優點。您可以提高生產力,改善風味和質地,並消除不必要的化學物質。食品製造商正在將生物催化劑作為一種永續且有效的解決方案,以滿足因客戶偏好不斷變化和對便利性的渴望而推動的全球加工食品日益成長的需求。因此,市場成長的需求不斷增加。
新型生物催化劑的開發和研究需要大量的資金。複雜的生物過程、高科技設備和科學技能都需要大量的財務支出。即使在研發完成後,長期的現場測試和法規認證也需要持續的支出。此外,由於該行業的高資本支出要求,小型企業和新興企業無法進入市場。因此,這是市場拓展的主要障礙。
生物製藥製造為生物催化劑和生物催化劑的應用提供了巨大的機會。由於單株抗體、酵素和重組蛋白等生物製藥在治療各種疾病方面的有效性和特異性,對它們的需求正在迅速增加。生物催化過程可以提高製造這些複雜分子的效率、產量和成本效益,有助於個人化醫療和標靶治療的進步。生物催化劑和生物催化劑市場即將成長,並為各產業的發展提供了許多機會。
生物催化劑和生物催化劑市場正面臨越來越多的環境影響問題。雖然生物催化劑透過實現高效和選擇性的化學過程提供了一種環境友善的替代,但人們對其生產、基材採購和廢棄物管理提出了擔憂。環境永續性至關重要,要求工業公司採取永續實踐,最大限度地減少資源消耗,並利用可再生資源開發生物催化劑。此外,重點是最佳化生物催化過程,以減少能源使用和廢棄物產生。
COVID-19 疫情導致許多國家停工,導致市場終端用途產業出現一段時期的需求低迷時期。在三月中旬多出現購買狂潮之後,由於食品和其他必需品再次被囤積,對包裝的需求有所下降。此外,新冠肺炎 (COVID-19) 大流行已經影響了包括食品和飲料行業在內的許多公司的業務。疫情對全球生物催化劑運作以及這些嚴重依賴生物催化劑的產業的影響,直接限制了生物催化劑和生物催化劑市場的擴張。
由於水解酶在酶水解中的重要作用,預計其佔有率最大。水解酶,包括蛋白酶、脂肪酶和澱粉酶,透過水解催化作用複雜的生物分子分解成更簡單的化合物。這個過程在食品加工、製藥、生物燃料和污水處理等多種應用中都至關重要。此外,水解酶的特異性、效率和環境效益推動了對水解酶的需求,為傳統化學催化劑提供了綠色替代品。研究和開發的重點是提高酶穩定性、基材覆蓋率和製程效率,以擴大應用範圍並提高生物催化和生物催化劑市場的永續性。
由於快速成長和技術創新,食品和飲料領域預計在預測期內將出現良好成長。生物催化劑透過實現高效和永續的食品生產過程在該領域發揮著至關重要的作用。蛋白酶、澱粉酶和脂肪酶等酵素用於改善食品的風味、質地和營養成分。此外,它還可用於乳製品、烘焙、釀造、水果加工等生產,提高產品質量,同時減少能源消耗和廢棄物。隨著消費者健康意願的增強以及對永續實踐的日益關注,食品和飲料行業對生物催化劑的需求預計將激增,從而推動酶應用和生物加工技術的進步。
在估計期間,亞太地區佔據最大的市場佔有率。在該地區,人們對永續實踐的認知不斷提高以及對綠色化學解決方案的需求正在推動生物催化劑在製藥、食品和飲料以及生物燃料等多種應用中的成長。在生物技術和製藥產業崛起的推動下,中國、印度、日本和韓國等國家正成為該市場的主要參與者。此外,學術機構、研究機構和產業參與者之間的合作正在推動創新和技術進步,推動亞太生物催化劑和生物催化劑市場的發展,預計將大幅擴張並在全球佔據主導地位。
由於北美地區的強勁成長和發展,預計在預測期內將出現獲利成長。生物催化利用酵素等天然催化劑來加速化學反應,由於其永續的特性,在該地區獲得了巨大的關注。在北美,以美國和加拿大為主要參與者,各行業對生物催化劑的需求正在迅速成長,包括製藥、化學品、食品和飲料和飲料以及環境應用。此外,研發配合措施、與學術機構和企業相關人員的合作、生物技術和生物工程的金融投資等都有助於市場擴張。
According to Stratistics MRC, the Global Biocatalysis & Biocatalysts Market is accounted for $13.31 billion in 2023 and is expected to reach $23.56 billion by 2030 growing at a CAGR of 8.5% during the forecast period. The term "biocatalyst" refers to compounds with a biological (non-human) origin that have the ability to catalyse a variety of processes. They are organic, biodegradable, and have high catalytic efficiency, in addition to having the advantage of being able to function in mild settings. They are employed for several industrial and commercial applications. Widely used application areas of biocatalysts encompass biopharmaceuticals, agriculture, textile, biofuels, and other life science applications.
According to the United States Department of Agriculture (USDA), in 2018, Canada's total food and beverage industry sector sales reached $87 billion.
In processed foods, natural bioenzymes are increasingly replacing chemical-based additions. Additionally, a number of studies have shown that the biopreservatives added to processed foods are better for digestive health than dangerous chemicals. In the processing of food, biocatalysis, which uses organic catalysts like enzymes, has many benefits. It allows for increased productivity, greater flavour and texture modification, and the elimination of unwanted chemicals. Food manufacturers are turning to biocatalysts as sustainable and effective solutions in response to the rising global demand for processed foods, which is being driven by shifting customer preferences and the desire for convenience. Thus, there is an increasing demand for market growth.
New biocatalyst development and research require significant financial resources. Complex biological processes, high-tech equipment, and scientific skills all need significant financial outlays. Long-term field trials and regulatory certifications require ongoing spending even after research and development work is finished. Furthermore, small and medium-sized businesses and startups are prevented from entering the market due to the significant capital expenditure requirements of the industry. Therefore, it is a significant barrier to the market's expansion.
Biopharmaceutical manufacturing presents a significant opportunity for the application of biocatalysis and biocatalysts. The demand for biopharmaceuticals, including monoclonal antibodies, enzymes, and recombinant proteins, is rapidly increasing due to their effectiveness and specificity in treating various diseases. Biocatalytic processes can improve the efficiency, yield, and cost-effectiveness of manufacturing these complex molecules, contributing to the advancement of personalised medicine and targeted therapies. The biocatalysis and biocatalysts market is poised for growth and offers numerous opportunities for advancement in various industries.
The biocatalysis and biocatalysts market faces growing concern regarding its environmental impact. While biocatalysts offer eco-friendly alternatives by enabling efficient and selective chemical processes, concerns arise about their production, substrate sourcing, and waste management. Environmental sustainability is pivotal, urging industry players to adopt sustainable practices, minimise resource consumption, and develop biocatalysts from renewable sources. Furthermore, there's an emphasis on optimising biocatalytic processes to reduce energy usage and waste generation.
The COVID-19 epidemic has caused many countries to shut down, which has resulted in a period of low demand from the market's end-use industries. Food and other necessities are once again being stockpiled after widespread frenzied purchasing in several locations in mid-March, which is causing the demand for packaging to decline. Additionally, during lockdown, the COVID-19 pandemic is having an impact on the operations of numerous companies, including the food and beverage sector. The influence of the pandemic on the global operation of these industries, which heavily rely on biocatalysis and biocatalysts, is directly limiting the expansion of the biocatalysis and biocatalysts market.
The Hydrolases segment is estimated to hold the largest share, due to its vital role in enzymatic hydrolysis. Hydrolases, including proteases, lipases, and amylases, catalyse the breakdown of complex biomolecules into simpler compounds through hydrolysis. This process is crucial in various applications such as food processing, pharmaceuticals, biofuels, and wastewater treatment. Additionally, the demand for hydrolases is driven by their specificity, efficiency, and environmental benefits, offering a green alternative to traditional chemical catalysts. Research and development efforts are focusing on enhancing enzyme stability, substrate range, and process efficiency to expand the applications and improve sustainability in the biocatalysis and biocatalyst markets.
The Food & Beverages segment is anticipated to have lucrative growth during the forecast period, due to its rapid growth and innovation. Biocatalysts play a pivotal role in this sector by enabling efficient and sustainable food production processes. Enzymes such as proteases, amylases, and lipases are used to improve the flavours, textures, and nutritional profiles of food products. Moreover, they aid in the production of dairy, baking, brewing, and fruit processing, enhancing product quality while reducing energy consumption and waste. With a growing focus on health-conscious consumers and sustainable practices, the demand for biocatalysts in the food and beverage industry is expected to surge, driving advancements in enzymatic applications and bioprocessing techniques.
Asia Pacific commanded the largest market share during the extrapolated period. The region's increasing awareness of sustainable practices and the demand for green chemistry solutions drive the growth of biocatalysts in diverse applications such as pharmaceuticals, food and beverages, biofuels, and more. Countries like China, India, Japan, and South Korea are emerging as key players in this market, leveraging their thriving biotechnology and pharmaceutical industries. Additionally, collaborations between academic institutions, research organisations, and industry players are fostering innovation and technological advancements, propelling the Asia-Pacific Biocatalysis and Biocatalysts Market, which is expected to have significant expansion and dominance on a worldwide scale.
North America is expected to witness profitable growth over the projection period, due to its robust growth and evolution. Biocatalysis, employing natural catalysts like enzymes to drive chemical reactions, has gained significant traction in the region due to its environmentally friendly and sustainable attributes. North America, comprising the United States and Canada as major players, is witnessing a surge in demand for biocatalysts across various industries such as pharmaceuticals, chemicals, food and beverages, and environmental applications. Moreover, initiatives for research and development, partnerships between academic institutions and business stakeholders, and financial investments in biotechnology and bioengineering all contribute to the market's expansion.
Some of the key players in the Biocatalysis & Biocatalysts Market: E.I. Dupont De Nemours & Co., Codexis Inc., AB Enzymes Gmbh, Novozymes A/S, Dyadic International Inc., Royal DSM N.V., BASF SE, Arzeda Corporation, Chr. Hansen, The Soufflet Group, Amano Enzyme Inc., Debut Biotechnology, Inc., Zymtronix Catalytic Systems Inc., Unilever PLC, Soufflet Agro Rus, LLC, RP Management LLC, Piramal Enterprises Ltd., Codexis Inc., Lonza Group Ltd. and Afton Chemical.
In September 2023, Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives. Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today's and tomorrow's plant-based meat products with advanced texture and consumer-friendly labels.
In February 2023, AB Enzymes and Barentz sign exclusive distribution agreement extension. AB Enzymes and Barentz have announced the extension of the distribution agreement for bake & food enzymes in most of Europe with Barentz. The 5-year agreement further strengthens AB Enzymes' ambitions in the European markets.